LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 190 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.88 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $703 | +234.8% | 24,327 | +735.7% | 0.00% | +100.0% |
Q2 2023 | $210 | -1.9% | 2,911 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $214 | +10.3% | 2,911 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $194 | -99.9% | 2,911 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $251,000 | -3.5% | 2,911 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $260,000 | -20.5% | 2,911 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $327,000 | -38.1% | 2,911 | -14.9% | 0.00% | -50.0% |
Q4 2021 | $528,000 | +10.7% | 3,421 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $477,000 | +6.2% | 3,421 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $449,000 | -14.0% | 3,421 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $522,000 | +53.5% | 3,421 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $340,000 | +4.3% | 3,421 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $326,000 | -14.9% | 3,421 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $383,000 | +38.8% | 3,421 | -10.0% | 0.00% | 0.0% |
Q1 2020 | $276,000 | -30.3% | 3,801 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $396,000 | +4.8% | 3,801 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $378,000 | -12.9% | 3,801 | 0.0% | 0.00% | -33.3% |
Q2 2019 | $434,000 | -17.3% | 3,801 | -9.1% | 0.00% | 0.0% |
Q1 2019 | $525,000 | -7.4% | 4,180 | 0.0% | 0.00% | -25.0% |
Q4 2018 | $567,000 | -50.6% | 4,180 | 0.0% | 0.00% | -42.9% |
Q3 2018 | $1,147,000 | +32.4% | 4,180 | 0.0% | 0.01% | +16.7% |
Q2 2018 | $866,000 | +25.5% | 4,180 | 0.0% | 0.01% | +20.0% |
Q1 2018 | $690,000 | +4.4% | 4,180 | -13.5% | 0.01% | +25.0% |
Q4 2017 | $661,000 | +0.5% | 4,830 | 0.0% | 0.00% | -20.0% |
Q3 2017 | $658,000 | +12.3% | 4,830 | 0.0% | 0.01% | +25.0% |
Q2 2017 | $586,000 | +14.7% | 4,830 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $511,000 | +2.4% | 4,830 | -1.7% | 0.00% | 0.0% |
Q4 2016 | $499,000 | -0.6% | 4,914 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $502,000 | -19.3% | 4,914 | -5.8% | 0.00% | -20.0% |
Q2 2016 | $622,000 | -7.3% | 5,216 | -16.8% | 0.01% | -16.7% |
Q1 2016 | $671,000 | -1.3% | 6,270 | 0.0% | 0.01% | 0.0% |
Q4 2015 | $680,000 | +26.6% | 6,270 | 0.0% | 0.01% | +20.0% |
Q3 2015 | $537,000 | -16.9% | 6,270 | -2.0% | 0.01% | 0.0% |
Q2 2015 | $646,000 | -1.1% | 6,400 | -24.5% | 0.01% | 0.0% |
Q1 2015 | $653,000 | +44.8% | 8,472 | 0.0% | 0.01% | +25.0% |
Q4 2014 | $451,000 | +13.3% | 8,472 | 0.0% | 0.00% | +33.3% |
Q3 2014 | $398,000 | -24.6% | 8,472 | 0.0% | 0.00% | -25.0% |
Q2 2014 | $528,000 | -7.4% | 8,472 | 0.0% | 0.00% | -20.0% |
Q1 2014 | $570,000 | +27.8% | 8,472 | 0.0% | 0.01% | +25.0% |
Q4 2013 | $446,000 | +21.5% | 8,472 | 0.0% | 0.00% | +33.3% |
Q3 2013 | $367,000 | +15.8% | 8,472 | 0.0% | 0.00% | 0.0% |
Q2 2013 | $317,000 | – | 8,472 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knott David M Jr | 115,000 | $7,682 | 2.90% |
VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |